Search Results - "Delaini, F"

The effect of very-low-dose warfarin on markers of hypercoagulation in metastatic breast cancer: results from a randomized trial by Falanga, A, Levine, M N, Consonni, R, Gritti, G, Delaini, F, Oldani, E, Julian, J A, Barbui, T

“…Malignancy is a risk factor for thromboembolism and anti-cancer chemotherapy can increase this risk. Prophylaxis of thrombosis with very-low-dose warfarin…”
Get more information

Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery by Falanga, A, Ofosu, F A, Cortelazzo, S, Delaini, F, Consonni, R, Caccia, R, Longatti, S, Maran, D, Rodeghiero, F, Pogliani, E

“…This study investigated whether the pre-surgical plasma levels of TAT and F1 + 2 of patients undergoing major surgery for localized tumours could identify…”
Get more information

Effect of Proteasome Inhibitors and/or Immunomodulatory Drugs on the Risk of Early Death of 991 Newly Diagnosed Symptomatic Multiple Myeloma Patients: A Single Centre Retrospective Analysis by Galli, Monica, Paris, Laura, Pavoni, Chiara, Delaini, Federica, Rambaldi, Alessandro

“…Introduction and aim : Several clinical trials have shown that the incorporation of novel agents (i.e., proteasome inhibitor, bortezomib and immunomodulatory…”
Get full text

The hypercoagulable state in cancer patients: evidence for impaired thrombin inhibitions by Falanga, A, Ofosu, F A, Delaini, F, Oldani, E, Dewar, L, Lui, L, Barbui, T

“…Activation of prothrombin and the subsequent reactions of thrombin with its substrates and its major inhibitors, antithrombin III (AT III) and heparin cofactor…”
Get more information

Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events by Bertani, T, Poggi, A, Pozzoni, R, Delaini, F, Sacchi, G, Thoua, Y, Mecca, G, Remuzzi, G, Donati, M B

“…Adriamycin has been suspected of causing experimental nephrotoxicity. We report here that adriamycin induces a nephrotic syndrome in rats, proteinuria…”
Get more information

PS1257 LYMPHOCYTE TO MONOCYTE RATIO (LMR) PREDICTS PROGRESSION‐FREE SURVIVAL INDEPENDENTLY FROM FLIPI AND IS USEFUL IN IDENTIFYING PATIENTS WITH EARLY DISEASE PROGRESSION by Gritti, G., Pavoni, C., Ferrari, S., Stefanoni, P., Rossi, A., Delaini, F., Barbui, A.M., Rambaldi, A.

“…Background: Despite the overall good prognosis of follicular lymphoma (FL), approximately 20 to 30% of the cases experience early progression after first line…”
Get full text

Renal response to atrial peptides is reduced in experimental nephrosis by Perico, N, Delaini, F, Lupini, C, Remuzzi, G

“…The aim of this study was to evaluate the renal response to atrial extracts (AE) and synthetic atrial natriuretic factor (ANF) in control rats and in rats with…”
Get full text

High cure rates in Burkitt lymphoma and leukemia: a Northern Italy Leukemia Group study of the German short intensive rituximab-chemotherapy program by Intermesoli, Tamara, Rambaldi, Alessandro, Rossi, Giuseppe, Delaini, Federica, Romani, Claudio, Pogliani, Enrico Maria, Pagani, Chiara, Angelucci, Emanuele, Terruzzi, Elisabetta, Levis, Alessandro, Cassibba, Vincenzo, Mattei, Daniele, Gianfaldoni, Giacomo, Scattolin, Anna Maria, Di Bona, Eros, Oldani, Elena, Parolini, Margherita, Gökbuget, Nicola, Bassan, Renato

“…We evaluate the long-term results of a prospective clinical study enrolling more than 100 adult patients with Burkitt lymphoma/leukemia. Depending on extent of…”
Get full text

Blunted excretory response to atrial natriuretic peptide in experimental nephrosis by Perico, Norberto, Delaini, Federica, Lupini, Cristina, Benigni, Ariela, Galbusera, Miriam, Boccardo, Paola, Remuzzi, Giuseppe

“…Blunted excretory response to atrial natriuretic peptide in experimental nephrosis. Adriamycin (ADR) nephrosis and a model of unilateral ADR-induced…”
Get full text

Hydroxyurea does not appreciably reduce JAK2 V617F allele burden in patients with polycythemia vera or essential thrombocythemia by ANTONIOLI, Elisabetta, CAROBBIO, Alessandra, RAMBALDI, Alessandro, BARBUI, Tiziano, VANNUCCHI, Alessandro M, PIERI, Lisa, PANCRAZZI, Alessandro, GUGLIELMELLI, Paola, DELAINI, Federica, PONZIANI, Vanessa, BARTALUCCI, Niccolò, TOZZI, Lorenzo, BOSI, Alberto

Get full text

Effect of platelet-activating factor and its specific receptor antagonist on glomerular permeability to proteins in isolated perfused rat kidney by Perico, N, Delaini, F, Tagliaferri, M, Abbate, M, Cucchi, M, Bertani, T, Remuzzi, G

“…Platelet-activating factor (PAF) is a lipid mediator of inflammation believed to play a role in glomerulonephritis by favoring immune complex formation and…”
Get more information

PF655 PROGNOSTIC RELEVANCE OF THE GENE EXPRESSION SIGNATURE IN PRIMARY AND SECONDARY MYELOFIBROSIS by Rontauroli, S., Zini, R., Bianchi, E., Genovese, E., Carretta, C., Parenti, S., Fantini, S., Mallia, S., Castellano, S., Guglielmelli, P., Pietra, D., Rumi, E., Salmoiraghi, S., Delaini, F., Mora, B., Elli, L., Accetta, R., Villani, L., Azzan, C., Rosti, V., Passamonti, F., Rambaldi, A., Cazzola, M., Vannucchi, A.M., Tagliafico, E., Manfredini, R.

“…Background: Primary myelofibrosis (PMF) together with polycythemia vera (PV) and essential thrombocythemia (ET) belongs to the classic Philadelphia‐negative…”
Get full text

Hemostatic system activation in patients with lupus anticoagulant and essential thrombocythemia by Falanga, A, Ofosu, F A, Cortelazzo, S, Delaini, F, Marziali, S, Barbui, T

“…Hemostatic system activation was estimated in the plasmas of 39 patients with LAC and 19 patients with ET by measuring concentrations of TAT complex and…”
Get more information

PF227 PROGNOSTIC VALUE OF CLONAL HEMATOPOIESIS‐MUTATIONS DETECTED AT DIAGNOSIS IN ACUTE MYELOID LEUKEMIA PATIENTS WITH NORMAL KARYOTYPE by Caprioli, C., Spinelli, O., Salmoiraghi, S., Intermesoli, T., Zanghì, P., Cavagna, R., Michelato, A., Buklijas, K., Elidi, L., Delaini, F., Oldani, E., Gianfaldoni, G., Bosi, A., Marmont, F., Audisio, E., Ferrero, D., Terruzzi, E., De Paoli, L., Rossi, G., Borlenghi, E., Cavattoni, I., Tajana, M., Scattolin, A.M., Mattei, D., Corradini, P., Campiotti, L., Ciceri, F., Bernardi, M., Todisco, E., Cortelezzi, A., Cortelazzo, S., Falini, B., Pavoni, C., Bassan, R., Rambaldi, A., Lussana, F.

“…Background: Mutations in DNA and chromatin regulation genes have been associated with clonal hematopoiesis (CH) in older healthy subjects, but are also…”
Get full text

PS1468 IMPACT OF CYTOREDUCTIVE DRUGS ON SECOND CANCER IN MYELOPROLIFERATIVE NEOPLASMS by Barbui, T., Ghirardi, A., Masciulli, A., Carobbio, A., Palandri, F., Vianelli, N., De Stefano, V., Betti, S., Di Veroli, A., Iurlo, A., Cattaneo, D., Delaini, F., Bonifacio, M., Scaffidi, L., Patriarca, A., Rumi, E., Stephenson, C., Guglielmelli, P., Elli, E.M., Miroslava, P., Bertolotti, L., Erez, D., Gomez, M., Wille, K., Perez‐Encinas, M., Lunghi, F., Angona, A., Fox, M.L., Beggiato, E., Benevolo, G., Carli, G., Cacciola, R., McMullin, M.F., Tieghi, A., Recasens, V., Marchetti, M., Griesshammer, M., Alvarez‐Larran, A., Vannucchi, A., Finazzi, G.

“…Background: The evidence that currently used cytoreductive agents may affect the risk of second cancer (SC) remains uncertain because patients with…”
Get full text

Tertatolol ameliorates renal function in rats with chronic renal failure by Delaini, F, Perico, N, Tagliaferri, M, Lupini, C, Patino, O, Remuzzi, G, Garattini, S

“…Tertatolol is a new beta-blocking agent which induces renal vasodilation in experimental animals and humans and increases glomerular filtration rate (GFR),…”
Get more information

Enhanced affinity for arachidonic acid in platelet-rich plasma from rats with Adriamycin-induced nephrotic syndrome by Delaini, F, Poggi, A, Donati, M B

“…We have measured the response to arachidonic acid (AA) in platelet-rich plasma (PRP) of rats with Adriamycin-induced nephrotic syndrome. For this purpose we…”
Get more information

The influence of selenium intake on chronic adriamycin toxicity and lipid peroxidation in rats by Facchinetti, T, Delaini, F, Salmona, M, Donati, M B, Feuerstein, S, Wendel, A

“…This paper reports on the influence of selenium intake on antioxidant protective systems during chronic adriamycin (AM) treatment in rats. Rats were kept for…”
Get more information

Cancer cell procoagulant: a novel vitamin K-dependent activity by Delaini, F, Colucci, M, De Bellis Vitti, G, Locati, D, Poggi, A, Semeraro, N, Donati, M B

Get more information

Platelet survival and function in rats with enhanced thrombotic tendency by Delaini, F, Dejana, E, Reyers, I, Vicenzi, E, De Bellis Vitti, G, Poggi, A, Donati, M B

“…We have investigated the relevance of some laboratory tests of platelet function in predicting conditions of thrombotic tendency. For this purpose, we studied…”
Get more information